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INTRODUCTION Background
Apneic oxygenation consists in the administration of oxygen during the apneic period of the intubation procedure to extend the safe apnea time beyond that which can be achieved by preoxygenation alone. [1] [2] [3] [4] [5] This concept was first introduced in the operating room setting, 6 and more recently its use has been rapidly adopted during airway management in the emergency department (ED) and ICU. [7] [8] [9] [10] The rationale for apneic oxygenation revolves around the physiologic capacity of continuous oxygen capture by alveoli through a passive process without providing ventilation. 6, 11 During laryngoscopy, apneic oxygenation may be provided as continuous oxygen delivery throughout the intubation with nasal cannulas, nasopharyngeal catheters, and modified laryngoscopes.
Importance
Airway management is commonly performed by anesthesiologists, emergency physicians, and critical care providers as part of their daily practice. Most intubations are performed in the operating room under controlled, often ideal situations. However, out-of-operating-room intubations have been associated with higher risks of adverse events because they are frequently performed urgently in critically ill patients, 12 for whom the rates of severe complications can be as high as 28%. 13 Hypoxemia is an adverse effect that can occur during intubation.
14 If oxygen were administered through the pharynx during the apneic period, one could increase the uptake of oxygen into the bloodstream, thus reducing occurrences of potentially harmful oxygen desaturation events.
Editor's Capsule Summary
What is already known on this topic Apneic oxygenation may prolong safe apnea time and increase first-pass success during emergency intubation.
What question this study addressed Is apneic oxygenation, typically delivered by high-flow nasal cannula, associated with lower peri-intubation hypoxemia and higher first-pass intubation success?
What this study adds to our knowledge In this meta-analysis of 8 emergency department and ICU studies comprising 1,837 patients, apneic oxygenation was associated with lower odds of peri-intubation hypoxemia (SpO 2 <93%; odds ratio 0.66; 95% confidence interval 0.52 to 0.85) and higher odds of first-pass intubation success (odds ratio 1.59; 95% confidence interval 1.04 to 2.44).
How this is relevant to clinical practice
These results support the role of apneic oxygenation in emergency intubation.
Goals of This investigation
The use of apneic oxygenation has been recommended by experts for management of high-risk airway situations, including emergency intubations in the ED, 10 and for patients at risk for difficult laryngoscopy and intubation in the operating room 15 ; however, the evidence supporting apneic oxygenation is still not well established. The objective of this systematic review and meta-analysis was to evaluate the effectiveness of apneic oxygenation on hypoxemia, first-pass success, and lowest oxygen saturation during emergency intubation.
MATERIALS AND METHODS Study Design
This was a systematic review and meta-analysis conducted to evaluate the effectiveness of apneic oxygenation during intubations performed in the ED and ICU settings. A protocol was developed a priori and it is available for access in the PROSPERO Web site. This report adheres to recommendations made in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. 16 
Eligibility Criteria
We included original research articles, including randomized controlled trials and observational studies, in which apneic oxygenation was used as part of the intubation procedure. We did not exclude any studies according to language, and only studies published in the past 10 years were included. This time restriction was based on the recent implementation of apneic oxygenation in clinical practice and advances in capnography and intubation monitoring in the included settings.
Studies of pediatric and adult patients who received apneic oxygenation during the apneic period of intubation in the ED or ICU were included. Studies performed in the out-of-hospital setting and in the operating room were excluded. There was no restriction by age, sex, or any other baseline characteristic.
To meet the eligibility criteria, patients had to have received oxygen during the apneic period. All types of oxygen devices were considered, including standard nasal cannula, high-flow nasal cannula, nasopharyngeal catheters, modified laryngoscopes, or any other device. Apneic oxygenation is most commonly performed with high-flow nasal cannula through the transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) technique and with standard nasal cannula through the technique of nasal oxygen during efforts securing a tube (NO DESAT). The THRIVE technique consists of the use of a high-flow warmed humidified oxygen delivery system up to 70 L/min to perform both preoxygenation and apneic oxygenation. This technique combines the benefits of apneic oxygenation with continuous positive airway pressure and gaseous exchange through flow-dependent dead-space flushing. 17, 18 The technique of NO DESAT uses a standard nasal cannula with cold dry oxygen set as high as 15 L/min, together with the traditional techniques of preoxygenation, and allows apneic oxygenation to continue while attempts at intubation are performed. 10, 19 Outcome Measures and Study Selection
The following outcomes were included: lowest SpO 2 periintubation; first-pass success (success on the first laryngoscopy attempt); incidences of hypoxemia (SpO 2 <93%), severe hypoxemia (SpO 2 <80%), and lifethreatening hypoxemia (SpO 2 <70%) during the procedure; duration of mechanical ventilation; ICU length of stay; and mortality in the ICU. In studies in which an episode of hypoxemia was defined by SpO 2 less than 90%, these events were included as episodes of SpO 2 less than 93%.
A medical librarian (P.J.E.) designed and conducted a comprehensive search of 4 electronic databases, including Ovid MEDLINE, Ovid EMBASE, Ovid CENTRAL, and Scopus from 2006 to July 2016. The initial search was designed in Ovid MEDLINE (Appendix E1, available online at http://www.annemergmed.com) and then translated into terms appropriate to Ovid CENTRAL and Ovid EMBASE. The strategies used a combination of controlled vocabulary (in MEDLINE, this is Medical Subject Headings), eg, "intubation," "intratracheal," text words. This was done for each concept: intubation, setting (eg, ED), purpose (apneic oxygenation), and outcomes (eg, hypoxemia). Gray literature databases suggested by the Cochrane handbook, 20 ongoing trials (through clinicaltrials.gov), and reference lists of eligible articles were hand searched.
In phase 1, 2 investigators (L.O.J.S. and D.C.), working independently, screened all titles and abstracts for eligibility. Records considered potentially relevant were assessed in full text for eligibility by 2 independent reviewers (L.O.J.S. and D.C.) in phase 2. We used Cohen's unweighted k to measure chance corrected agreement between reviewers for phase 2. Disagreements were discussed with the senior author (M.F.B.) and resolved by consensus. All studies were included for qualitative analysis and only those with available data were included for the quantitative analysis.
Primary Data Analysis
Pertinent data were extracted with a standardized predefined form. Data from the first 10 studies were extracted at the beginning of the process independently in duplicate by 2 reviewers (L.O.J.S. and P.B.) to identify variables prone to misinterpretation. Extracted data included study design, study size, study setting, study population, details of the intubation procedure, and outcomes of interest. In regard to the intubation procedure, data collected included clinical predictors of difficult intubation (ie, Cormack-Lehane grades III and IV), methods of preoxygenation, use of rapid sequence intubation, context for intubation, proceduralist expertise (trainee versus expert), and type of laryngoscope used. Trainee proceduralist was defined as physicians undergoing a training program (residents and fellows). Expert proceduralist was defined as emergency physicians, intensivists, and anesthesiologists.
For randomized controlled trials, we assessed the risk of bias with the Cochrane Collaboration Bias Appraisal Tool. 20 We assessed the risk of bias for observational studies with a modified Newcastle-Ottawa Scale tool. 21 Quality assessment of all studies included was performed in duplicate and independently by 2 reviewers (L.O.J.S. and P.B.). The quality of evidence for the main outcomes was evaluated with the Grading of Recommendations Assessment, Development and Evaluation methods. 22 We collected the outcomes included in the published reports, and authors were contacted by e-mail if data were missing or unclear. Most studies contained the desired clinical outcomes. We directly contacted the authors of the 14 studies and received additional data from 12. One conference abstract of an ongoing trial had no data for outcomes of interest. 23 We considered it reasonable to pool the data from ED and ICU studies to have a better understanding of the overall benefit of apneic oxygenation in an emergency setting. Data were managed following Cochrane recommendations. 20 We used Review Manager (version 5.3; The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark) for meta-analyses, using a random-effects model as described by DerSimonian-Laird. 24 The pooled-effect estimates of using apneic oxygenation during intubation versus not using it were reported as odds ratio (OR) and weighted mean difference with 95% confidence intervals (CIs). Statistical heterogeneity was assessed among studies by the I 2 statistic proposed by Higgins and Thompson. 25 Between-studies heterogeneity was also evaluated visually.
To account for the clinical and statistical heterogeneity between studies, we used a random-effects model. During the development of the protocol, we planned to perform subgroup analyses by proceduralist expertise, study design, and risk of bias. Sensitivity analyses were conducted excluding studies with high risk of bias.
RESULTS
The search strategy identified 1,386 studies for review ( Figure 1 ). After screening the titles and abstracts and removing duplicates, we identified 77 potentially relevant studies. After full-text review, a total of 14 studies met the inclusion criteria: 6 ICU studies, [26] [27] [28] [29] [30] [31] 6 ED studies, 23, [32] [33] [34] [35] [36] and 2 mixed ED and ICU studies. 37, 38 Interobserver agreement (k) for phase 2 of study selection was moderate (k 0.54; 95% CI 0.34 to 0.74), with an overall agreement of 79.2% (95% CI 70.2% to 88.3%).
Among the studies including patients intubated in the ED or ICU, there were 9 observational studies and 5 randomized controlled trials (Table 1 and Appendix E2, available online at http://www.annemergmed.com).
The included studies involved 2,023 participants, with 1,168 patients receiving apneic oxygenation during intubation and 855 not receiving it. Eight studies, 26, 27, [29] [30] [31] [32] 35, 38 including 982 patients receiving apneic oxygenation and 855 not receiving it, underwent meta-analysis. Three studies had no control groups, 33,34,37 1 study had both arms receiving apneic oxygenation, 28 and 1 conference abstract did not have enough data details. 23 There were 2 studies with overlapping cohorts, and we included only the most comprehensive one in the meta-analyses. 35, 36 Two ED studies included pediatric patients within a mixed pediatric and adult cohort, 32, 38 with a median age greater than 50 years. Most studies included patients with acute respiratory failure requiring emergency intubation. Apneic oxygenation was performed through high-flow nasal cannula in most studies, 26, 28, 30, 31, 34, 37 with the oxygen flow set as high as 60 L/min. Standard nasal cannula with oxygen set as high as 15 L/min, used in combination with traditional techniques of preoxygenation, was mostly used in the ED studies. 32, 35, 36, 38 
Main Results
We evaluated the body of evidence for the main outcomes with the Grading of Recommendations Assessment, Development and Evaluation approach, which assessed the confidence in our meta-analytic effects accounting for different criteria rather than the risk of bias alone (Table 2 and Appendix E3, available online at http://www.annemergmed. com). Sources of clinical heterogeneity included setting and context for intubation, approaches to preoxygenation and apneic oxygenation, and proceduralist expertise.
The timeframe for measurement of the lowest periintubation SpO 2 and incidences of hypoxemia were unclear in most studies; among those that reported it in detail, it was measured from drug injection until the initiation of mechanical ventilation.
In the meta-analysis of 6 studies including 1,043 patients, 26, 27, [29] [30] [31] 35 the lowest peri-intubation SpO 2 was higher for apneic oxygenation than standard oxygenation (difference 2.21%; 95% CI 0.81% to 3.61%; I 2 ¼0%) (Figure 2A ).
In the meta-analysis of 6 studies including 1,658 patients, 25, 26, 28, 30, 31, 34 apneic oxygenation during intubation was associated with increased first-pass success rates (OR 1.59; 95% CI 1.04 to 2.44; I 2 ¼48%) ( Figure 2B ). Hypoxemia was defined differently across studies. For the meta-analysis, we defined hypoxemia as SpO 2 less than 93%. In studies in which an episode of hypoxemia was defined by SpO 2 less than 90%, these events were included as episodes of SpO 2 less than 93%. In the meta-analysis of 8 studies including 1,837 patients, 26, 27, [29] [30] [31] [32] 35 ,38 apneic oxygenation during intubation was associated with decreased incidence of hypoxemia (OR 0.66; 95% CI 0.52 to 0.84; I 2 ¼0%) ( Figure 2C ). 
Low
Observ., Observational studies; MD, mean difference. *Other considerations include assessment of publication bias, magnitude of effect, plausible confounding, and dose-response gradient. † ApOx may have a larger effect in less sick populations intubated in the ED/ICU, as shown indirectly by the increased safe apnea time when using ApOx in elective intubated patients in the operating room without cardiorespiratory disease. ‡ Different approaches to ApOx (NO DESAT vs THRIVE) could also play a role in the direction of effect. § Inclusion of a before-after observational study with high risk of bias (Fogg 32 ); however, when sensitivity analysis was performed excluding this study, there was still a benefit of using ApOx. jj ApOx may have larger effect when trainees perform intubations. { Inclusion of 2 studies with high risk of bias (Fogg 32 and Dyett 38 ); however, when sensitivity analysis excluding these studies was performed, there was still a benefit of using ApOx. # 95% CI around the pooled estimate of effect includes both benefit and no benefit of using ApOx. In the meta-analysis of 6 studies including 1,043 patients, 26, 27, [29] [30] [31] 35 apneic oxygenation during intubation was not associated with severe hypoxemia (SpO 2 <80%) (OR 0.86; 95% CI 0.47 to 1.57; I 2 ¼44%) ( Figure 2D ). In the meta-analysis of 5 studies including 1,003 patients, 26, 27, 29, 31, 35 apneic oxygenation during intubation was not associated with life-threatening hypoxemia (SpO 2 <70%) (OR 0.90; 95% CI 0.52 to 1.55; I 2 ¼2%) ( Figure 2E ).
In the meta-analysis of 4 studies including 368 patients, 26, 27, 29, 31 apneic oxygenation during intubation was not associated with decreased duration of mechanical ventilation (weighted mean difference 1.42 days; 95% CI 0.59 to 3.42; I 2 ¼63%) ( Figure 3A ). In the meta-analysis of 4 studies including 368 patients, 26, 27, 29, 31 apneic oxygenation during intubation was associated with a decreased ICU length of stay of 2.88 days (95% CI 1.40 to 4.37 days; I 2 ¼0%) ( Figure 3B ). In the meta-analysis of 4 studies including 258 patients, 26 ,27,30,31 apneic oxygenation was not associated with ICU mortality (OR 0.82; 95% CI 0.38 to 1.76; I 2 ¼32%). Deaths included 36 of 118 patients (30.5%) in the apneic oxygenation group and 49 of 140 (35.0%) in the control group, with an absolute difference of -4% (95% CI -18% to 14%) ( Figure 3C ).
Additional Analyses
Forest plots of subgroup analyses by proceduralist expertise, study design, and risk of bias are shown in Appendix E4, available online at http://www. annemergmed.com. Apneic oxygenation favored the trainees' subgroup when proceduralist expertise was evaluated; however, differences between subgroups were not statistically significant. Sensitivity analysis excluding the study with high risk of bias 32 did not significantly change the pooled effect estimates. When randomized controlled trials and studies with low risk of bias were analyzed separately, apneic oxygenation was not associated with better periprocedural outcomes.
We were unable to statistically assess the presence of publication bias because the number of studies included in each analysis was small, which makes analysis of funnel plots unreliable. 39 
LIMITATIONS
There are several limitations in this systematic review and meta-analysis. The major limitation relates to the quality of included studies, which warrants a moderate to low level of certainty in the estimates. Another important limitation is the different approaches used to apneic oxygenation in terms of preoxygenation and other periintubation variables and cointerventions. The different methods of preoxygenation between groups could affect the likelihood of developing hypoxemia during the apneic period; therefore, the effect of apneic oxygenation was not isolated in some of the included studies. The maintenance of airway patency during apneic oxygenation was not described in most of the studies, and that might affect the quality of this intervention. The clinical heterogeneity of patients intubated in the ED and ICU in regard to their cardiorespiratory baseline status is also an important factor to be considered, and which approach is better among the spectrum of sickness in patients requiring emergency intubation still has to be studied.
To decrease selection bias, we included all eligible studies including those published in gray literature and not indexed in PubMed or major databases, and abstracts. We included all studies even if they had a low number of participants or high risk of bias. This likely introduced heterogeneity into the analyses. However, we assessed clinical and statistical heterogeneity and accounted for this in the statistical analyses. To mitigate some of these limitations, we used subgroup analyses. Also we contacted the authors when published data were not clear or missing, and we received several responses.
DISCUSSION
This systematic review and meta-analysis demonstrated that the use of apneic oxygenation during intubation appears to be associated with increased peri-intubation oxygen saturation and first-pass success rates, as well as decreased incidence of hypoxemia in patients intubated in the ED or ICU. The use of apneic oxygenation was associated with a decrease in ICU length of stay, but there was no difference in duration of mechanical ventilation and ICU mortality. We found no reports of adverse events related to the use of apneic oxygenation, despite different approaches and settings.
The concept and use of apneic oxygenation for the optimization of peri-intubation conditions, especially apnea time, has been introduced in the practice of emergency medicine after ED observational studies, 32, 35, 38 anesthesiology literature, 1, 3, 4 and recommendations by experts in the field. 10, 19 EDs and ICUs have used different techniques for apneic oxygenation, with most ICU studies using high-flow nasal cannula and most ED studies using the standard nasal cannula. 32, 35, 36, 38 The THRIVE technique combines preoxygenation and apneic oxygenation using a high-flow nasal cannula up to 70 L/min, creating a flowdependent positive pharyngeal pressure, with potentially more benefit for patients with more severe respiratory disease. 8, 40 The relative simplicity and safety of this intervention and the potential to turn intubation in a safer procedure, with higher success rates and fewer complications, led to a rapid and widespread use of the concept and to its even being considered by some as standard of care despite relatively scarce evidence to support its use. 10 Recently, ICU-based studies have shown conflicting results on the effectiveness of apneic oxygenation using different approaches. [26] [27] [28] [29] [30] [31] Patients intubated outside of the operating room represented emergency intubations in the setting of critical illness in an ED or ICU environment, in whom the lowest SpO 2 and incidences of hypoxemia during the peri-intubation period are different from those in the elective operating room population. Although there was variable level of bias and heterogeneity in the included studies, apneic oxygenation was associated with increased SpO 2 peri-intubation, increased first-pass success rates, and decreased incidence of hypoxemia in patients intubated in the ED or ICU. Severe and life-threatening hypoxemia was not affected. These findings likely represent an overall benefit of using apneic oxygenation during emergency intubations, reflecting better periprocedural outcomes and prolonged safe apnea time. The physiologic improvements noted likely have little effect on the underlying disease, which may explain the lack of improvement in mortality.
In the subgroup analysis, proceduralist experience showed that peri-intubation oxygen saturation, first-pass success, and hypoxemia were improved in the trainees' subgroup; however, these outcomes were not significantly improved in the experts' subgroup. The potential decrease in hypoxemia in urgently intubated patients with the use of apneic oxygenation might have allowed less experienced operators more time for laryngoscopy, and thus led them to achieve higher first-pass success rates. Apneic oxygenation may be of less benefit to operators who are very skilled at laryngoscopy and can complete intubation quickly. 35 Higher first-pass success rates could also explain the decreased incidence of hypoxemia, given the direct relationship between number of attempts and the incidence of desaturations, 9, 35, 41 and secondary increase in patients' safety. 35 Subgroup analysis by risk of bias showed that when only studies with low risk of bias were included, none of the outcomes analyzed showed an improvement with the use of apneic oxygenation, likely because the sample sizes were significantly reduced; however, this also raises a concern about the quality of the evidence of the available studies in regard to the use of apneic oxygenation.
In summary, in this meta-analysis apneic oxygenation was associated with increased peri-intubation SpO 2 , decreased hypoxemia, and increased first-pass intubation success. Apneic oxygenation is a potentially important adjunct for emergency airway management. All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
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Ovid CENTRAL: 253 results
The asterisk (*) is a commonly used "wildcard" symbol that broadens a search by finding words that start with the same letters. Use it with distinctive word stems to retrieve variations of a term with less typing.
APPENDIX E3 Risk-of-Bias Assessment of ED and ICU Studies
Cochrane Collaboration's tool for assessment of risk of bias in randomized controlled trials. 
